Cognitive enhancement and antipsychotic-like activity following repeated dosing with the selective M PAM VU0467154.

Gould RW, Grannan MD, Gunter BW, Ball J, Bubser M, Bridges TM, Wess J, Wood MW, Brandon NJ, Duggan ME, Niswender CM, Lindsley CW, Conn PJ, Jones CK
Neuropharmacology. 2018 128: 492-502

PMID: 28729220 · PMCID: PMC6756753 · DOI:10.1016/j.neuropharm.2017.07.013

MeSH Terms (19)

Allosteric Regulation Animals Antipsychotic Agents Brain Cognition Disorders Discrimination, Psychological Disease Models, Animal Dizocilpine Maleate Dose-Response Relationship, Drug Hyperkinesis Male Memory Disorders Mice Mice, Inbred C57BL Mice, Knockout Pyridazines Receptor, Muscarinic M4 Schizophrenia Thiophenes

Connections (2)

This publication is referenced by other Labnodes entities: